CCTV4: Heritage and Harmony Beneath the Full Moon, The World Is Invited to the CMG 2025 Mid-Autumn Festival Gala
BEIJING, Oct. 3, 2025 /PRNewswire/ — This year, for its Mid-Autumn Festival Gala, China Media Group invites you to …
BEIJING, Oct. 3, 2025 /PRNewswire/ — This year, for its Mid-Autumn Festival Gala, China Media Group invites you to …
The Lisk EMpower Fund targets post-incubation Web3 startups in Africa, Latin America, and Southeast Asia, bridging the ca…
HONG KONG, Oct. 2, 2025 /PRNewswire/ — A landmark study conducted by The Hong Kong University of Science and Techno…
MILAN, Oct. 2, 2025 /PRNewswire/ — OSL Pay, an international digital asset payment infrastructure provider, announc…
BEIJING, Oct. 2, 2025 /PRNewswire/ — The China International Industrial Technology and Smart Manufacturing (Japan) …
With the additions of RapDev, Calitii and Waivgen, Synechron now leads the sector with the most comprehensive and globall…
SINGAPORE, Oct. 2, 2025 /PRNewswire/ — During the globally watched Token2049 Summit, Vitalik Buterin, co-found…
NEW YORK, Oct. 2, 2025 /PRNewswire/ — Amber International Holding Limited (Nasdaq: AMBR), operating under the brand…
LISBON, Portugal, Oct. 2, 2025 /PRNewswire/ — The European Central Bank (ECB) has concluded a framework agreement i…
NEW YORK, Oct. 2, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directl…
New collaboration will expand SI Group’s customer reach complementing its long-standing partnership with Brenntag T…
GUANGZHOU, China, Oct. 2, 2025 /PRNewswire/ — On September 30, with just 40 days remaining before the ope…
SHANGHAI, Oct. 2, 2025 /PRNewswire/ — At Wonder Festival 2025, Assembly Character Toys brand Blokees launched&…
Practical cleaning tips and exclusive product offers to keep homes fresh, cozy, and guest-ready this fall SEATTLE, Oct. 2…
$75m funding round will fuel mission to protect financial institutions and consumers from fraud and scams LISBON, Portuga…
The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the sam…